LAINGAX Trademark

Trademark Overview

On Tuesday, November 21, 2017, a trademark application was filed for LAINGAX with the United States Patent and Trademark Office. The USPTO has given the LAINGAX trademark a serial number of 87693311. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 12, 2021. This trademark is owned by Tanvex BioPharma, Inc.. The LAINGAX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
laingax

General Information

Serial Number87693311
Word MarkLAINGAX
Filing DateTuesday, November 21, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTanvex BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKYI-1205
KY
Party NameTanvex BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKYI-1205
KY

Trademark Events

Event DateEvent Description
Monday, July 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020EXTENSION 5 GRANTED
Thursday, November 12, 2020EXTENSION 5 FILED
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 12, 2020TEAS EXTENSION RECEIVED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020EXTENSION 4 GRANTED
Monday, May 11, 2020EXTENSION 4 FILED
Monday, May 11, 2020TEAS EXTENSION RECEIVED
Friday, November 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2019EXTENSION 3 GRANTED
Wednesday, November 6, 2019EXTENSION 3 FILED
Wednesday, November 6, 2019TEAS EXTENSION RECEIVED
Monday, June 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2019EXTENSION 2 GRANTED
Wednesday, May 8, 2019EXTENSION 2 FILED
Wednesday, May 8, 2019TEAS EXTENSION RECEIVED
Wednesday, November 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 5, 2018EXTENSION 1 GRANTED
Monday, November 5, 2018EXTENSION 1 FILED
Monday, November 5, 2018TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Monday, December 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

laingax cancer pharmaceutical blood preparations treatments including those conditions caused treatment